ORIGINAL RESEARCH
Accepted on 11 Mar 2025
A prediction model based on machine learning: prognosis of HBVinduced HCC male patients with smoking and drinking habits after local ablation treatment
doi 10.3389/fimmu.2025.1464863
- Frontiers in Medicine
- Translational Medicine
- Research Topics
- Hepatocellular Carcinoma: Novel Treatment Strategies - Volume III
Hepatocellular Carcinoma: Novel Treatment Strategies - Volume III
8,167
Total downloads
24k
Total views and downloads
Articles
REVIEW
Published on 03 Mar 2025
Adverse events associated with hepatic arterial infusion chemotherapy and its combination therapies in hepatocellular carcinoma: a systematic review
doi 10.3389/fimmu.2025.1531249
- 175 views
ORIGINAL RESEARCH
Published on 13 Feb 2025
Creation of an innovative diagnostic framework for hepatocellular carcinoma employing bioinformatics techniques focused on senescence-related and pyroptosis-related genes
doi 10.3389/fonc.2025.1485421
- 501 views
ORIGINAL RESEARCH
Published on 10 Jan 2025
Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience
doi 10.3389/fimmu.2024.1474442
- 397 views
ORIGINAL RESEARCH
Published on 12 Dec 2024
Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy
doi 10.3389/fimmu.2024.1508028
- 503 views
ORIGINAL RESEARCH
Published on 12 Dec 2024
Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
doi 10.3389/fonc.2024.1495321
- 518 views
ORIGINAL RESEARCH
Published on 05 Dec 2024
Immune-checkpoint HLA-G gene polymorphisms, 3’-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population
doi 10.3389/fimmu.2024.1459749
- 646 views
BRIEF RESEARCH REPORT
Published on 22 Nov 2024
Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis
doi 10.3389/fonc.2024.1482909
- 527 views
CASE REPORT
Published on 20 Nov 2024
The survival and safety of metastatic hepatocellular carcinoma treated with lenalidomide as second-line therapy: a case report and review of the literature
doi 10.3389/fonc.2024.1461936
- 489 views
SYSTEMATIC REVIEW
Published on 11 Nov 2024
Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review
doi 10.3389/fimmu.2024.1487353
- 991 views
MINI REVIEW
Published on 25 Oct 2024
Therapeutic advances in hepatocellular carcinoma: an update from the 2024 ASCO annual meeting
doi 10.3389/fonc.2024.1453412
- 2,504 views
ORIGINAL RESEARCH
Published on 03 Oct 2024
The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studies
doi 10.3389/fonc.2024.1427332
- 563 views
Published in
Frontiers in Medicine
Translational Medicine
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore